Epidemiological Profile of Ophthalmological Care in the Public Service in Brazil (EPP)

December 6, 2012 updated by: Instituto de Olhos de Goiania
Epidemiological study about eye discomfort complaints, comorbidities and diagnosis at a Brazil's ophthalmological public care service

Study Overview

Status

Completed

Conditions

Detailed Description

  1. 1670 individuals underwent an ophthalmologic evaluation
  2. The data were obtained through the analysis of the medical records with the ICD-10 registration
  3. The studied variables were age and sex of patient, origin, eye discomfort complaints, comorbidities and diagnosis (ICD-10).
  4. The purpose was to evaluate epidemiological aspects of eye diseases in a public service

Study Type

Observational

Enrollment (Actual)

1670

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Brazil
    • Goias
      • Goiania, Goias, Brazil, 74110120
        • Instituto de Olhos de Goiania

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Individuals underwent an ophthalmologic evaluation

Description

Inclusion Criteria:

  • Patients assisted in public service

Exclusion Criteria:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Ocular diseases
Observational

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence and prevalence of visual conditions in the Public Service in Brazil
Time Frame: 6 months
  • The ages ranged from 0 to 99 years
  • The mean age was 56.9 years
  • There was a predominance of females (58.1%)
  • The main reason for the consultation was low visual acuity (70%), followed by burning (26%) and itchiness (24.4%)
  • Among the abnormal tests there was a high prevalence of refractive errors (73.4%) and presbyopia (59.6%)
  • The cause of refractive errors was astigmatism (70.5%), hypertrophy (58.6%) and myopia (15.1%)
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Instituto de Olhos de Goiania

Investigators

  • Study Chair: Marisa N Figueiredo, IOG

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2012

Primary Completion (Actual)

July 1, 2012

Study Completion (Actual)

August 1, 2012

Study Registration Dates

First Submitted

November 30, 2012

First Submitted That Met QC Criteria

December 3, 2012

First Posted (Estimate)

December 4, 2012

Study Record Updates

Last Update Posted (Estimate)

December 7, 2012

Last Update Submitted That Met QC Criteria

December 6, 2012

Last Verified

December 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Epidemiological public profile

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Eye Abnormalities

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe